Burr DB - Search Results

1

Alendronate reduces bone toughness of ribs without significantly increasing microdamage accumulation in dogs following 3 years of daily treatment.

Allen MR, Reinwald S, Burr DB. Allen MR, et al. Among authors: burr db. Calcif Tissue Int. 2008 May;82(5):354-60. doi: 10.1007/s00223-008-9131-8. Epub 2008 May 8. Calcif Tissue Int. 2008. PMID: 18463913 Free PMC article.

2

Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate.

Allen MR, Iwata K, Phipps R, Burr DB. Allen MR, et al. Among authors: burr db. Bone. 2006 Oct;39(4):872-9. doi: 10.1016/j.bone.2006.04.028. Epub 2006 Jun 12. Bone. 2006. PMID: 16765660 Free article.

3

Raloxifene enhances vertebral mechanical properties independent of bone density.

Allen MR, Iwata K, Sato M, Burr DB. Allen MR, et al. Among authors: burr db. Bone. 2006 Nov;39(5):1130-1135. doi: 10.1016/j.bone.2006.05.007. Epub 2006 Jun 30. Bone. 2006. PMID: 16814622

4

Raloxifene enhances material-level mechanical properties of femoral cortical and trabecular bone.

Allen MR, Hogan HA, Hobbs WA, Koivuniemi AS, Koivuniemi MC, Burr DB. Allen MR, et al. Among authors: burr db. Endocrinology. 2007 Aug;148(8):3908-13. doi: 10.1210/en.2007-0275. Epub 2007 May 3. Endocrinology. 2007. PMID: 17478550 Free article.

5

Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment.

Allen MR, Burr DB. Allen MR, et al. Among authors: burr db. J Bone Miner Res. 2007 Nov;22(11):1759-65. doi: 10.1359/jbmr.070720. J Bone Miner Res. 2007. PMID: 17663638 Free article.

6

Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment.

Allen MR, Burr DB. Allen MR, et al. Among authors: burr db. J Oral Maxillofac Surg. 2008 May;66(5):987-94. doi: 10.1016/j.joms.2008.01.038. J Oral Maxillofac Surg. 2008. PMID: 18423290 Free PMC article.

7

The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data.

Allen MR, Burr DB. Allen MR, et al. Among authors: burr db. J Oral Maxillofac Surg. 2009 May;67(5 Suppl):61-70. doi: 10.1016/j.joms.2009.01.007. J Oral Maxillofac Surg. 2009. PMID: 19371816 Free article. Review.

8

Effects of 1 to 3 years' treatment with alendronate on mechanical properties of the femoral shaft in a canine model: implications for subtrochanteric femoral fracture risk.

Burr DB, Diab T, Koivunemi A, Koivunemi M, Allen MR. Burr DB, et al. J Orthop Res. 2009 Oct;27(10):1288-92. doi: 10.1002/jor.20895. J Orthop Res. 2009. PMID: 19396816 Free PMC article.

9

Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs.

Allen MR, Kubek DJ, Burr DB. Allen MR, et al. Among authors: burr db. J Bone Miner Res. 2010 Jan;25(1):98-105. doi: 10.1359/jbmr.090713. J Bone Miner Res. 2010. PMID: 19580463 Free PMC article.

10

Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading.

Feher A, Koivunemi A, Koivunemi M, Fuchs RK, Burr DB, Phipps RJ, Reinwald S, Allen MR. Feher A, et al. Among authors: burr db. Bone. 2010 Jan;46(1):203-7. doi: 10.1016/j.bone.2009.10.023. Epub 2009 Oct 24. Bone. 2010. PMID: 19857619

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters